Merck & Company, Inc. Free Cash Flow 2007–2025
Merck & Company, Inc. reported $12.36B of free cash flow for fiscal 2025. That was 31.7% lower than fiscal 2024. Compared with fiscal 2020, the change was +112.2%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $12.36B | -31.7% |
| FY 2024 | $18.10B | +97.9% |
| FY 2023 | $9.14B | -37.8% |
| FY 2022 | $14.71B | +69.6% |
| FY 2021 | $8.67B | +48.9% |
| FY 2020 | $5.82B | -42.2% |
| FY 2019 | $10.07B | +21.2% |
| FY 2018 | $8.31B | +82.1% |
| FY 2017 | $4.56B | -47.9% |
| FY 2016 | $8.76B | -22.2% |
| FY 2015 | $11.26B | +68.7% |
| FY 2014 | $6.67B | -34.0% |
| FY 2013 | $10.11B | +25.3% |
| FY 2012 | $8.07B | -24.3% |
| FY 2011 | $10.66B | +16.6% |
| FY 2010 | $9.14B | +373.5% |
| FY 2009 | $1.93B | -63.4% |
| FY 2008 | $5.27B | -11.9% |
| FY 2007 | $5.99B | — |
Source: Merck & Company, Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open MRK 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Merck & Company, Inc. reported $12.36B of free cash flow for fiscal 2025. That was 31.7% lower than fiscal 2024. Compared with fiscal 2020, the change was +112.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Merck & Company, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeMerck & Company, Inc. — frequently asked questions
What is Merck & Company, Inc.'s free cash flow?
Merck & Company, Inc. (MRK) reported free cash flow of $12.36B for fiscal year 2025, per its SEC filings.
How has Merck & Company, Inc.'s free cash flow changed over time?
Between fiscal 2007 and 2025, MRK's free cash flow grew at roughly 4.1% per year (compound annual rate), from $5.99B to $12.36B.
Where does this data come from?
Figures are computed from Merck & Company, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.